Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Research in academic medical centers: two threats to sustainable support.

Levine AS, Alpern RJ, Andrews NC, Antman K, Balser JR, Berg JM, Davis PB, Fitz JG, Golden RN, Goldman L, Jameson JL, Lee VS, Polonsky KS, Rappley MD, Reece EA, Rothman PB, Schwinn DA, Shapiro LJ, Spiegel AM.

Sci Transl Med. 2015 May 27;7(289):289fs22. doi: 10.1126/scitranslmed.aac5200.

PMID:
26019216
2.

Learning about medical student mistreatment from responses to the medical school graduation questionnaire.

Mavis B, Sousa A, Lipscomb W, Rappley MD.

Acad Med. 2014 May;89(5):705-11. doi: 10.1097/ACM.0000000000000199.

3.

The College of Human Medicine at Michigan State University: expansion and reinvention.

Mavis B, Sousa A, Osuch J, Arvidson C, Lipscomb W, Brady J, Green W, Rappley MD.

Acad Med. 2012 Dec;87(12):1705-9. doi: 10.1097/ACM.0b013e318271f8c6. Erratum in: Acad Med. 2013 Jan;88(1):101.

PMID:
23095925
4.

Adequacy of two ambulatory care surveillance systems for tracking childhood obesity practice patterns.

Eneli IU, Keast DR, Rappley MD, Camargo CA Jr.

Public Health. 2008 Jul;122(7):700-7. doi: 10.1016/j.puhe.2007.10.001. Epub 2008 Mar 3.

PMID:
18313702
5.

Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control.

Nigg JT, Knottnerus GM, Martel MM, Nikolas M, Cavanagh K, Karmaus W, Rappley MD.

Biol Psychiatry. 2008 Feb 1;63(3):325-31. Epub 2007 Sep 14.

6.

The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD.

Waldman ID, Nigg JT, Gizer IR, Park L, Rappley MD, Friderici K.

Cogn Affect Behav Neurosci. 2006 Mar;6(1):18-30.

PMID:
16869226
7.

ADHD drugs and cardiovascular risk.

Rappley MD, Moore JW, Dokken D.

N Engl J Med. 2006 May 25;354(21):2296-8; author reply 2296-8. No abstract available.

PMID:
16729375
8.

Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems.

Counts CA, Nigg JT, Stawicki JA, Rappley MD, von Eye A.

J Am Acad Child Adolesc Psychiatry. 2005 Jul;44(7):690-8.

PMID:
15968238
9.

Clinical practice. Attention deficit-hyperactivity disorder.

Rappley MD.

N Engl J Med. 2005 Jan 13;352(2):165-73. Review. No abstract available.

PMID:
15647579
10.

Attention-deficit/hyperactivity disorder in children and adolescents: interventions for a complex costly clinical conundrum.

Greydanus DE, Pratt HD, Sloane MA, Rappley MD.

Pediatr Clin North Am. 2003 Oct;50(5):1049-92, vi. Review.

PMID:
14558681
11.

Psychopharmacology of ADHD in adolescents.

Greydanus DE, Sloane MA, Rappley MD.

Adolesc Med. 2002 Oct;13(3):599-624. Review.

PMID:
12270803
12.

Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder.

Rappley MD, Eneli IU, Mullan PB, Alvarez FJ, Wang J, Luo Z, Gardiner JC.

J Dev Behav Pediatr. 2002 Feb;23(1):23-30.

PMID:
11889348
13.

Neuropsychological executive functions and DSM-IV ADHD subtypes.

Nigg JT, Blaskey LG, Huang-Pollock CL, Rappley MD.

J Am Acad Child Adolesc Psychiatry. 2002 Jan;41(1):59-66.

PMID:
11800208
14.

Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.

Rappley MD, Mullan PB, Alvarez FJ, Eneli IU, Wang J, Gardiner JC.

Arch Pediatr Adolesc Med. 1999 Oct;153(10):1039-45.

PMID:
10520611
15.

Safety issues in the use of methylphenidate. An American perspective.

Rappley MD.

Drug Saf. 1997 Sep;17(3):143-8. Review.

PMID:
9306050
16.

The use of methylphenidate in Michigan.

Rappley MD, Gardiner JC, Jetton JR, Houang RT.

Arch Pediatr Adolesc Med. 1995 Jun;149(6):675-9.

PMID:
7767425
17.

Retinal hemorrhage predicts neurologic injury in the shaken baby syndrome.

Wilkinson WS, Han DP, Rappley MD, Owings CL.

Arch Ophthalmol. 1989 Oct;107(10):1472-4.

PMID:
2803095

Supplemental Content

Loading ...
Support Center